The potential of mesenchymal stromal cells as a novel cellular therapy for multiple sclerosis. Auletta JJ, Bartholomew AM, Maziarz RT, Deans RJ, Miller RH, Lazarus HM, Cohen JA Immunotherapy. 2012 May; 4(5):529-47. PMID: 22642335. Abstract CommentRecommendBookmarkWatch